Document Detail


Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT.
MedLine Citation:
PMID:  17652190     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To retrospectively compare sensitivity and specificity of magnetic resonance (MR) imaging, three-dimensional (3D) MR spectroscopy, combined MR imaging and 3D MR spectroscopy, and carbon 11 (11C)-choline positron emission tomography (PET)/computed tomography (CT) for intraprostatic tumor sextant localization, with histologic findings as reference standard. MATERIALS AND METHODS: The local ethics committee on human research provided approval and a waiver of informed consent for the retrospective study. MR imaging, 3D MR spectroscopy, and 11C-choline PET/CT results were retrospectively reviewed in 26 men with biopsy-proved prostate cancer (mean age, 64 years; range, 51-75 years) who underwent radical prostatectomy. Cancer was identified as areas of nodular low signal intensity on T2-weighted MR images. At 3D MR spectroscopy, choline-plus-creatine-to-citrate and choline-to-creatine ratios were used to distinguish healthy from malignant voxels. At PET/CT, focal uptake was visually assessed, and maximum standardized uptake values (SUVs) were recorded. Agreement between 3D MR spectroscopic and PET/CT results was calculated, and ability of maximum SUV to help localize cancer was assessed with receiver operating characteristic analysis. Significant differences between positive and negative sextants with respect to mean maximum SUV were calculated with a paired t test. RESULTS: Sensitivity, specificity, and accuracy were, respectively, 55%, 86%, and 67% at PET/CT; 54%, 75%, and 61% at MR imaging; and 81%, 67%, and 76% at 3D MR spectroscopy. The highest sensitivity was obtained when either 3D MR spectroscopic or MR imaging results were positive (88%) at the expense of specificity (53%), while the highest specificity was obtained when results with both techniques were positive (90%) at the expense of sensitivity (48%). Concordance between 3D MR spectroscopic and PET/CT findings was slight (kappa=0.139). CONCLUSION: In localizing cancer within the prostate, comparable specificity was obtained with either 3D MR spectroscopy and MR imaging or PET/CT; however, PET/CT had lower sensitivity relative to 3D MR spectroscopy alone or combined with MR imaging.
Authors:
Claudia Testa; Riccardo Schiavina; Raffaele Lodi; Eugenio Salizzoni; Barbara Corti; Mohsen Farsad; John Kurhanewicz; Fabio Manferrari; Eugenio Brunocilla; Caterina Tonon; Nino Monetti; Paolo Castellucci; Stefano Fanti; Manuela Coe; Walter F Grigioni; Giuseppe Martorana; Romeo Canini; Bruno Barbiroli
Publication Detail:
Type:  Comparative Study; Journal Article     Date:  2007-07-24
Journal Detail:
Title:  Radiology     Volume:  244     ISSN:  0033-8419     ISO Abbreviation:  Radiology     Publication Date:  2007 Sep 
Date Detail:
Created Date:  2007-08-21     Completed Date:  2007-10-18     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0401260     Medline TA:  Radiology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  797-806     Citation Subset:  AIM; IM    
Copyright Information:
Copyright (c) RSNA, 2007.
Affiliation:
Department of Clinical Medicine and Applied Biotechnology D. Campanacci, Diagnostic Imaging Section V. Bollini, Pathologic Anatomy Unit, Institute of Oncology F. Addarii, P.E.T. Center, Policlinico S. Orsola-Malpighi, University of Bologna, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Biopsy
Carbon Radioisotopes / diagnostic use
Choline / diagnostic use
Humans
Image Processing, Computer-Assisted
Imaging, Three-Dimensional
Magnetic Resonance Imaging
Magnetic Resonance Spectroscopy
Male
Middle Aged
Positron-Emission Tomography
Prostatectomy
Prostatic Neoplasms / diagnosis*,  pathology,  surgery
Retrospective Studies
Sensitivity and Specificity
Tomography, X-Ray Computed
Chemical
Reg. No./Substance:
0/Carbon Radioisotopes; 62-49-7/Choline

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The use of family health histories to address health disparities in an African American community.
Next Document:  Treatment of unruptured intracranial aneurysms: decision and cost-effectiveness analysis.